//September

US FDA Grants Once Daily Dosing Option For NITYR (nitisinone) Tablets for HT-1 Patients

By | September 14th, 2020|Generics, News|

Dr David Buckeridge Joins Cycle Pharmaceuticals’ Board of Directors

By | September 8th, 2020|Generics, News|

Cycle Pharmaceuticals Features in the Sunday Times Tech Track Ones to Watch 2020

By | September 8th, 2020|Generics, News|

Cycle Pharmaceuticals Secures $25 Million Debt Financing

By | September 5th, 2020|Generics, News|